References
- GrinesCLBonowROCaseyDEJrAmerican Heart Association; American College of CardiologySociety for Cardiovascular Angiography and InterventionsAmerican College of SurgeonsAmerican Dental AssociationAmerican College of PhysiciansPrevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stentsCirculation200711581381817224480
- RiedeFNPfistererMJegerRLong-term safety of drug-eluting stentsExpert Rev Cardiovasc Ther201311101359137824138523
- MoussaIDColomboAAntiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendationsCatheter Cardiovasc Interv20097471047105419626692
- WarrenJBaberUMehranRAntiplatelet therapy after drug-eluting stent implantationJ Cardiol20156529810425467922
- StefaniniGGTaniwakiMWindeckerSCoronary stents: novel developmentsHeart2014100131051106124006453
- PilgrimTWindeckerSDrug-eluting stent technology: progress beyond the polymerEur Heart J201435301991199524908391
- LüscherTFSteffelJEberliFRDrug-eluting stent and coronary thrombosis: biological mechanisms and clinical implicationsCirculation200711581051105817325255
- SudirKHermillerJBFergusonJMSimontonCARisk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapyISRN Cardiol2013201374873623862074
- AttizzaniGFCapodannoDOhnoYTamburinoCMechanisms, pathophysiology, and clinical aspects of incomplete stent appositionJ Am Coll Cardiol201463141355136724530675
- CookSWenaweserPTogniMIncomplete stent apposition and very late stent thrombosis after drug-eluting stent implantationCirculation2007115182426243417485593
- NakazawaGFinnAVKolodgieFDVirmaniRA review of current devices and a look at new technology: drug-eluting stentsExpert Rev Med Devices200961334219105778
- JonerMFinnAVFarbAPathology of drug-eluting stents in humans: delayed healing and late thrombotic riskJ Am Coll Cardiol200648119320216814667
- ByrneRAJonerMKastratiAPolymer coatings and delayed arterial healing following drug-eluting stent implantationMinerva Cardioangiol200957556758419838148
- ZhangHDengWWangXWangSGeJToftESolely abluminal drug release from coronary stents could possibly improve reendothelializationCatheter Cardiovasc Interv Epub20131210
- DanziGBChevalierBOstojicMHamilosMWijinsWNobori™ drug eluting stent system: clinical evidence updateMinerva Cardioangiol201058559961020948506
- MorettiCLolliVPeronaGCre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulationEuroIntervention2012791087109422130128
- SerruysPWFarooqVKalesanBImproved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (limus eluted from a durable versus ERodable stent coating) randomized, noninferiority trialJACC Cardiovasc Interv20136877778923968698
- WilsonGJHuibregtseBAPenningtonDEDawkinsKDComparison of the SYNERGY with the PROMUS (XIENCE V) and bare metal and polymer-only element control stents in porcine coronary arteriesEuroIntervention20128225025722717928
- GuagliumiGSirbuVMusumeciGStrut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: optical coherence tomography drug-eluting stent investigation (OCTDESI)Circ Cardiovasc Interv20103436737520647562
- MeredithITVerheyeSDuboisCLPrimary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stentJ Am Coll Cardiol201259151362137022341736
- MARUYAMA KAZUHIRO [JP]; SAITO NOBORU [JP]; GOTO HIROKI [JP] +, inventor; Maruyama K, Saito N, Goto H, assignee. Stent. World patent WO2011040218 (A1). 2010 Sept 13.
- BasalusMWTandjungKvan WestenTScanning electron microscopic assessment of coating irregularities and their precursors in unexpanded durable polymer-based drug-eluting stentsCatheter Cardiovasc Interv201279464465321805599
- BasalusMWvan HouwelingenKGAnkoneMde ManFHvon BirgelenCScanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stentsEuro-Intervention20095450551019755341
- LeeSLeeCWKimCSFEA study on the stress distributions in the polymer coatings of cardiovascular drug-eluting stent medical devicesAnn Biomed Eng20144291952196524889717
- HopkinsCGMcHughPEMcGarryJPComputational investigation of the delamination of polymer coatings during stent deploymentAnn Biomed Eng20103872263227320309730
- SeidlitzANagelSSemmlingBExamination of drug release and distribution from drug-eluting stents with a vessel-simulating flow-through cellEur J Pharm Biopharm2011781364821182943
- SemmlingBNagelSSternbergKWeitschiesWSeidlitzADevelopment of hydrophobized alginate hydrogels for the vessel-simulating flow-through cell and their usage for biorelevant drug-eluting stent testingAAPS PharmSciTech20131431209121823918507
- ZhuXPackDWBraatzRDModelling intravascular delivery from drug-eluting stents with biodurable coating: investigation of anisotropic vascular drug diffusivity and arterial drug distributionComput Methods Biomech Biomed Engin201417318719822512464
- O’BrienCCFinchCHBarberTJMartensPSimmonsAAnalysis of drug distribution from a simulated drug-eluting stent strut using an in vitro frameworkAnn Biomed Eng201240122687269622648579
- HwangCWWuDEdelmanERImpact of transport and drug properties on the local pharmacology of drug-eluting stentsInt J Cardiovasc Intervent20035171212623559
- BalakrishnanBTzafririARSeifertPGroothuisARogersCEdelmanERStrut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stentsCirculation2005111222958296515927969
- BalakrishananBDooleyJFKopiaGEdelmanERIntravascular drug release kinetics dictate arterial drug deposition, retention, and distributionJ Control Release2007123210010817868948
- SguegliaGAChevalierBKissing balloon inflation in percutaneous coronary interventionsJACC Cardiovasc Interv20125880381122917451
- SchwartzRSHuberKCMurphyJGRestenosis and the proportional neointimal response to coronary artery injury: results in a porcine modelJ Am Coll Cardiol19921922672741732351
- KornowskiRHongMKTioFOBramwellOWuHLeonMBIn-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasiaJ Am Coll Cardiol19983112242309426044
- SuzukiTKopiaGHayashiSStent-based delivery of sirolimus reduces neointimal formation in a porcine coronary modelCirculation2001104101188119311535578
- SteffelJLatiniRAAkhmedovARapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent designCirculation2005112132002201116172265
- CamiciGGSteffelJAmanovicIRapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stentsEur Heart J201031223624219567381
- OtsukaFFinnAVYazdaniSKNakanoMKolodgieFDVirmaniRThe importance of the endothelium in atherothrombosis and coronary stentingNat Rev Cardiol2012943945322614618
- NapoliKLWangMEStepkowskiSMKahanBDDistribution of sirolimus in rat tissueClin Biochem19973021351429127695
- BarbatoESalinger-MartinovicSSagicDA first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY studyEuroIntervention201511554154825136883
- StojkovicSNeskovicANMehmedbegovicZReduced sirolimus systemic exposure and improved bioresorbable polymer properties: new allies for the treatment of patients with coronary artery diseaseFundam Clin Pharmacol20152919510525223651
- ChenYWSmithMLSheetsMZotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppressionJ Cardiovasc Pharmacol200749422823517438408
- WesselyRBlaichBBelaibaRSComparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug deliveryThromb Haemost20079761003101217549304
- GaoRLXuBLanskyAJTARGET I InvestigatorsA randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trialEuroIntervention20139758323685298